Ladenburg Thalmann Financial Services’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | $516K | Buy |
6,448
+2,551
| +65% | +$204K | ﹤0.01% | 1790 |
|
|
2019
Q3 | $294K | Buy |
3,897
+1,678
| +76% | +$127K | ﹤0.01% | 2186 |
|
|
2019
Q2 | $338K | Buy |
2,219
+40
| +2% | +$6.09K | ﹤0.01% | 2051 |
|
|
2019
Q1 | $260K | Buy |
2,179
+822
| +61% | +$98.1K | ﹤0.01% | 2199 |
|
|
2018
Q4 | $147K | Sell |
1,357
-476
| -26% | -$51.6K | ﹤0.01% | 2469 |
|
|
2018
Q3 | $295K | Buy |
1,833
+585
| +47% | +$94.1K | ﹤0.01% | 2007 |
|
|
2018
Q2 | $93K | Hold |
1,248
| – | – | ﹤0.01% | 2795 |
|
|
2018
Q1 | $93K | Sell |
1,248
-1,534
| -55% | -$114K | ﹤0.01% | 2795 |
|
|
2017
Q4 | $155K | Sell |
2,782
-1,480
| -35% | -$82.5K | ﹤0.01% | 2407 |
|
|
2017
Q3 | $193K | Buy |
4,262
+2,493
| +141% | +$113K | ﹤0.01% | 2141 |
|
|
2017
Q2 | $59K | Buy |
1,769
+67
| +4% | +$2.24K | ﹤0.01% | 2915 |
|
|
2017
Q1 | $50K | Buy |
1,702
+498
| +41% | +$14.6K | ﹤0.01% | 2916 |
|
|
2016
Q4 | $33K | Sell |
1,204
-3,200
| -73% | -$87.7K | ﹤0.01% | 3149 |
|
|
2016
Q3 | $271K | Sell |
4,404
-488
| -10% | -$30K | ﹤0.01% | 1548 |
|
|
2016
Q2 | $93K | Buy |
4,892
+3,000
| +159% | +$57K | ﹤0.01% | 2208 |
|
|
2016
Q1 | $37K | Sell |
1,892
-13
| -0.7% | -$254 | ﹤0.01% | 2825 |
|
|
2015
Q4 | $73K | Hold |
1,905
| – | – | ﹤0.01% | 2298 |
|
|
2015
Q3 | $62K | Buy |
1,905
+628
| +49% | +$20.4K | ﹤0.01% | 2329 |
|
|
2015
Q2 | $39K | Hold |
1,277
| – | – | ﹤0.01% | 2765 |
|
|
2015
Q1 | $17K | Buy |
1,277
+1,000
| +361% | +$13.3K | ﹤0.01% | 3294 |
|
|
2014
Q4 | $4K | Buy |
+277
| New | +$4K | ﹤0.01% | 3835 |
|
|
2014
Q1 | – | Sell |
-300
| Closed | -$6K | – | 3841 |
|
|
2013
Q4 | $6K | Buy |
+300
| New | +$6K | ﹤0.01% | 3180 |
|